Thymosin Alpha 1 Overview

Thymosin Alpha 1 functions as a potent immunomodulator that influences immune cell development, cytokine expression, and immune system homeostasis. As a naturally occurring 28-amino acid peptide originally isolated from thymic tissue, Tα1 plays a fundamental role in T-cell maturation, immune cell differentiation, and innate and adaptive immune response regulation. Through toll-like receptor (TLR) pathway activation and immune cell signaling modulation, Tα1 has been investigated in research models examining T-cell maturation, dendritic cell function, natural killer cell activity, and multi-system immune responses in laboratory settings.

Liu et al. (2023). Romani et al. (2007).

History

Thymosin Alpha 1 was first isolated and characterized from bovine thymus gland in the 1970s by Allan Goldstein and colleagues at George Washington University. This peptide was identified as the primary active component of thymosin fraction 5, a crude thymic extract with immunological activity. Subsequent research established its role in T-cell differentiation and led to development as thymalfasin (Zadaxin) for clinical investigation.

Goldstein et al. (2010).

Thymosin Alpha 1 Structure

CAS#: 62304-98-7

Molecular Formula: C₁₂₉H₂₁₅N₃₃O₅₅

Molecular Weight: 3108.28 g/mol

PubChem ID: 16132341

Research Findings

Thymosin Alpha 1 has been examined in immunology research focusing on immune cell maturation, cytokine modulation, toll-like receptor signaling, and immunosenescence in various experimental models. Studies investigate its effects on T-cell populations, dendritic cell function, and immune system restoration across different physiological contexts.

Key Areas of Research:

• Immune cell development: T-cell maturation, CD4/CD8 differentiation, thymic function

• Immunomodulation: Cytokine regulation (IL-2, IL-12, IFN-γ), dendritic cell activation

• Cellular signaling: TLR pathway activation, immune receptor expression, antigen presentation

• Systemic immunity: Natural killer cell activity, immune senescence, multi-organ immune function

Together, these investigations reveal Tα1’s broad immunomodulatory properties across immune cell types and organ systems. Through TLR-dependent and independent mechanisms, Tα1 serves as a research tool for examining immune restoration, cellular differentiation pathways, and immune system aging in preclinical models and cell-based assays.

Liu et al., International Immunopharmacology, 2023

References

Liu Y. et al. (2023). Thymosin α-1 in cancer therapy: Immunoregulation and potential applications. International Immunopharmacology, 120:110067.

Romani L. et al. (2007). Thymosin alpha1: an endogenous regulator of inflammation, immunity, and tolerance. Annals of the New York Academy of Sciences, 1112:326-338.

Goldstein A.L. et al. (2010). Thymosin alpha 1: Biological activities, applications and genetic engineering. Expert Opinion on Biological Therapy, 10(11):1457-1470.